Thermo Fisher Scientific Inc. has announced a new compensation plan for its Chairman, President, and CEO, Marc N. Casper. The Board of Directors has approved the grant of performance-based restricted stock units, valued at approximately $60 million, designed to secure Mr. Casper's leadership through at least May 2030. The plan is linked to the company's total shareholder return (TSR) performance relative to the S&P 500 from May 2025 to December 2029. With a five-year cliff vesting period, the award aims to drive substantial returns to shareholders, with payouts adjusted based on TSR performance. This decision reflects Mr. Casper's success in guiding the company through various economic environments and the importance of maintaining executive leadership continuity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.